Kouya Shiraishi Selected Research

Kouya Shiraishi Research Topics

Disease

32	Neoplasms (Cancer) 05/2024 - 10/2010
10	Adenocarcinoma of Lung 10/2020 - 05/2010
7	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2009
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 12/2017
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 11/2010
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2023 - 01/2020
4	Endometrial Neoplasms (Endometrial Cancer) 05/2024 - 05/2022
2	Disease Progression 04/2024 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 05/2021
2	Protein Deficiency 01/2023 - 11/2021
2	Breast Neoplasms (Breast Cancer) 07/2020 - 06/2015
1	Microsatellite Instability 05/2024
1	Thymoma (Thymic Carcinoma) 04/2024
1	Carcinogenesis 02/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Infections 01/2023
1	Genomic Instability 01/2023
1	Endometrioid Carcinoma 05/2022
1	Residual Neoplasm 02/2022
1	Stomach Neoplasms (Stomach Cancer) 11/2021
1	Epstein-Barr Virus Infections 11/2021
1	Lymphatic Metastasis 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Endometriosis 10/2019
1	Hemorrhage 10/2019
1	Cicatrix (Scar) 10/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Adenocarcinoma in Situ 01/2019
1	Adenocarcinoma 01/2019
1	Idiopathic Pulmonary Fibrosis 11/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2015
1	Adenosquamous Carcinoma 06/2015
1	Papillary Thyroid Cancer 05/2014

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2014
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2014
5	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2014
4	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2015
4	PlatinumIBA 01/2023 - 11/2010
3	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2015
3	LigandsIBA 12/2023 - 02/2015
3	Messenger RNA (mRNA)IBA 02/2022 - 10/2020
3	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2015
2	pembrolizumabIBA 05/2024 - 04/2024
2	Phosphotransferases (Kinase)IBA 04/2024 - 07/2018
2	AntigensIBA 12/2023 - 11/2022
2	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2018
2	Exonucleases (3' 5' Exonuclease)IBA 01/2023 - 05/2022
2	Indicators and Reagents (Reagents)IBA 01/2018 - 12/2016
2	HLA-DQA1 antigen (HLA DQA1)IBA 04/2011 - 05/2010
2	Cholinergic ReceptorsIBA 01/2010 - 01/2009
2	Nicotine FDA Link 01/2010 - 01/2009
1	AntibodiesIBA 04/2024
1	lenvatinibIBA 04/2024
1	Epithelial Cell Adhesion MoleculeIBA 03/2024
1	SmokeIBA 02/2024
1	CarcinogensIBA 02/2024
1	Tobacco Smoke Pollution (Passive Smoking)IBA 02/2024
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 12/2023
1	Calcibiotic Root Canal SealerIBA 10/2023
1	Dihydrotachysterol (AT 10)IBA 02/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	HeterochromatinIBA 01/2023
1	DNA Polymerase IIIBA 01/2023
1	Therapeutic UsesIBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2021
1	GenieIBA 03/2021
1	Death Domain ReceptorsIBA 01/2021
1	NivolumabIBA 01/2021
1	ParaffinIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 11/2018
1	penicillamine-glutathione mixed disulfideIBA 11/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2018
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2018
1	Cytidine DeaminaseIBA 01/2018
1	Topoisomerase InhibitorsIBA 12/2017
1	Macrophage Migration-Inhibitory FactorsIBA 01/2017
1	cyclo(Arg-Pro) (CI 4)IBA 12/2015
1	Thymidylate SynthaseIBA 06/2015
1	TubulinIBA 06/2015
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2015
1	Interleukin-8 (Interleukin 8)IBA 02/2015
1	3' Untranslated Regions (3' UTR)IBA 02/2015

Therapy/Procedure

9	Therapeutics 09/2023 - 01/2018
6	Drug Therapy (Chemotherapy) 12/2023 - 11/2010
4	Chemoradiotherapy 01/2023 - 01/2015
2	Hysterectomy 05/2023 - 01/2021
2	Salpingo-oophorectomy 05/2023 - 11/2022
2	Radiotherapy 01/2021 - 01/2021
2	Precision Medicine 01/2021 - 06/2016
2	Immunotherapy 07/2018 - 02/2018
1	Molecular Targeted Therapy 01/2020
1	Episiotomy 10/2019
1	Adjuvant Chemotherapy 01/2012